| 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial … B Ibanez, S James, S Agewall, MJ Antunes, C Bucciarelli-Ducci, H Bueno, ... European heart journal 39 (2), 119-177, 2018 | 12125 | 2018 |
| Clinical end points in coronary stent trials: a case for standardized definitions DE Cutlip, S Windecker, R Mehran, A Boam, DJ Cohen, GA van Es, ... Circulation 115 (17), 2344-2351, 2007 | 6230 | 2007 |
| Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium R Mehran, SV Rao, DL Bhatt, CM Gibson, A Caixeta, J Eikelboom, S Kaul, ... Circulation 123 (23), 2736-2747, 2011 | 4502 | 2011 |
| Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document AP Kappetein, SJ Head, P Généreux, N Piazza, NM Van Mieghem, ... Journal of the American College of Cardiology 60 (15), 1438-1454, 2012 | 3983 | 2012 |
| Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium MB Leon, N Piazza, E Nikolsky, EH Blackstone, DE Cutlip, AP Kappetein, ... Journal of the American College of Cardiology 57 (3), 253-269, 2011 | 1602 | 2011 |
| Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial M Valgimigli, A Gagnor, P Calabró, E Frigoli, S Leonardi, T Zaro, ... The Lancet 385 (9986), 2465-2476, 2015 | 1449 | 2015 |
| Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial SS Anand, J Bosch, JW Eikelboom, SJ Connolly, R Diaz, P Widimsky, ... The Lancet 391 (10117), 219-229, 2018 | 980 | 2018 |
| Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy … P Vranckx, M Valgimigli, P Jüni, C Hamm, PG Steg, D Heg, GA van Es, ... The Lancet 392 (10151), 940-949, 2018 | 761 | 2018 |
| Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised … P Vranckx, M Valgimigli, L Eckardt, J Tijssen, T Lewalter, G Gargiulo, ... The Lancet 394 (10206), 1335-1343, 2019 | 673 | 2019 |
| Dual antiplatelet therapy after PCI in patients at high bleeding risk M Valgimigli, E Frigoli, D Heg, J Tijssen, P Jüni, P Vranckx, Y Ozaki, ... New England Journal of Medicine 385 (18), 1643-1655, 2021 | 390 | 2021 |
